Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

The US Government's exclusion of architecture from its list of "professional" degrees prompts an overdue discussion about the value of licensing, write Andrea Dietz and Peggy Deamer. On November 21, ...

SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

The field of architecture, historically dominated by men, is seeing a national shift with more women enrolling in programs. At Drury University, female students now outnumber male students in the five ...

The School of Architecture and Planning will host a distinguished lineup of designers, architects, authors and artists as part of its Fall 2025 Public Programs series. Free and open to the public, ...

Architects in Schools program reaches 5,000+ Oregon students. Scholarships expand statewide, awarding $67,500 in 2025. New mentorship program supports diverse design graduates. Focus on outreach to ...

Islamic architecture has long captivated observers with its harmonious blend of spirituality, geometry, and cultural expression. Originating in the 7th century CE, this architectural tradition spans ...

0x0000_0000_0000_0000 ┌─────────────────┐ │ ROM │ 128 KB 0x0000_0000_0002_0000 ├─────────────────┤ │ RAM │ 512 MB 0x0000_0000_2002_0000 ...